# Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme

> **NCT00574964** · PHASE2 · TERMINATED · sponsor: **University of Iowa** · enrollment: 50 (estimated)

## Conditions studied

- Primary Glioblastoma Multiforme

## Interventions

- **OTHER:** Gliadel Wafer, Temodar and Radiotherapy

## Key facts

- **NCT ID:** NCT00574964
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2007-11
- **Final completion:** 2008-06
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** PI left the institution.
- **Last updated:** 2016-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574964, "Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00574964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*